• Home
  • About
  • Webcasts
  • ‘Enforcement 40’ for 2020
  • Enforcement Hall of Fame
  • Contact
Securities Docket
Securities-Docket-Leaderboard_9Sec
  • Class Actions
  • Criminal
  • Global
  • People
  • SD Insider
  • SEC
  • Video
  • Subscribe by email
  • Subscribe
Browse: Home / 2009 / May / 26 / U.S. Supreme Court Grants Cert. in Appeal of Merck/Vioxx Securities Class Action Dismissal

U.S. Supreme Court Grants Cert. in Appeal of Merck/Vioxx Securities Class Action Dismissal

By Securities Docket on May 26, 2009, 11:34 am

The Supreme Court granted certiorari today in Merck & Co., et al., v. Reynolds, et al. (08-905), a case involving the issue of “inquiry notice” as it applies to federal securities fraud claims.

The specific “Question Presented,” as framed by the petitioners in their Petition for Writ of Certiorari (available here), is as follows:

Did the Third Circuit err in holding, in accord with the Ninth Circuit but in contrast to nine other Courts of Appeals, that under the “inquiry notice” standard applicable to federal securities fraud claims, the statute of limitations does not begin to run until an investor receives evidence of scienter without the benefit of any investigation?

In this case, shareholders alleged that Merck provided misleading information about the risks of Vioxx.  The U.S. District court dismissed the case on the grounds that the plaintiffs’ claims were time-barred under the statute of limitations.  However, the Third Circuit Court of Appeals reversed the lower court’s ruling (opinion available here, via SCOTUSBlog), allowing the case to proceed.

Blog Widget by LinkWithin

Posted in Class Actions | Tagged Appellate, Certiorari, Features, Supreme Court

« Previous Next »

‘Enforcement 40’ for 2020

Ankura 260x250

Our Sponsors

Securities-Docket_260x125_14Sec Ankura 260x125

Join Us On LinkedIn

Join the Securities Litigation and Enforcement Group on LinkedIn

Archives

Copyright © 2021 Securities Docket.

Powered by WordPress and Hybrid.